| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNI - EN REPORT No | 50 | / | 2013 | ||||||||
| Date of issue: | 2013-11-14 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Unaudited Interim Report for the Krka Group and the Krka Company for January-September 2013 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| See attached files. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Unaudited Interim Report for the Krka Group and the Krka Company for January-September 2013.pdf | Interim report January-September 2013 | ||||||||||
| Press release.pdf | Press release |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| | | KRKA, TOVARNA ZDRAVIL D.D. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | KRKA | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 8501 | | Nove Mesto | | | |
| | | (post code) | | (city) | | | |
| | | Smarjeska | | 6 | | | |
| | | (street) | | (number) | | | |
| | | +386 7 331 21 11 | | +386 7 332 15 37 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nie dotyczy | | | | | |
| | | (NIP)
| | | (REGON) | | |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
|---|---|---|---|---|---|
| Date | Name | Position / Function | Signature | ||
| 2013-11-14 | Jože Colarič | President of the Management Board |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
